Franklin, J. M., Platt, R., Dreyer, N. A., London, A. J., Simon, G. E., Watanabe, J. H., . . . Califf, R. M. (2022). When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments? Clinical pharmacology and therapeutics, 111(1), 108-115. https://doi.org/10.1002/cpt.2255
Citácia podle Chicago (17th ed.)Franklin, Jessica M., Richard Platt, Nancy A. Dreyer, Alex John London, Gregory E. Simon, Jonathan H. Watanabe, Michael Horberg, Adrian Hernandez, a Robert M. Califf. "When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?" Clinical Pharmacology and Therapeutics 111, no. 1 (2022): 108-115. https://doi.org/10.1002/cpt.2255.
Citácia podľa MLA (8th ed.)Franklin, Jessica M., et al. "When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?" Clinical Pharmacology and Therapeutics, vol. 111, no. 1, 2022, pp. 108-115, https://doi.org/10.1002/cpt.2255.